Two Loco Pilots Injured As Two Goods Trains Collide At Punjab’S Sirhind (WATCH)
The injured pilots were quickly taken to Sri Fatehgarh Sahib Civil Hospital for treatment. Fortunately, there have been no casualties reported from the incident. Ratan Lal, an official with the Government Railway Police (GRP) at Sirhind Police Station, confirmed that the pilots' conditions were being monitored and that there was no significant loss of goods or further life threats.
The collision has significantly disrupted the Ambala-Ludhiana train route, leading to delays and rerouting of subsequent rail traffic. The GRP, along with the Railway Protection Force (RPF) and senior railway officials including the Divisional Railway Manager (DRM) of the Ambala Division, were quick to the scene to assess the situation and begin an investigation into the cause of the accident.
“Our teams reached the spot shortly after the incident was reported, and the focus has been on providing immediate care to the injured and securing the area,” said Lal. He also noted that a full investigation is underway to determine the specifics of how the collision occurred and to prevent future incidents.
The rail section remains closed as the investigation continues, and updates are expected as more information becomes available.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Industry Leader The5ers Expands Funding Programs To U.S. Traders
- Excellion Finance Scales Market-Neutral Defi Strategies With Fordefi's MPC Wallet
- Xfunded Expands In Dubai, Strengthening Collaborations With Trading Influencers Across Europe
- Chaingpt Pad Unveils Buzz System: Turning Social Hype Into Token Allocation
- PLPC-DBTM: Non-Cellular Oncology Immunotherapy With STIPNAM Traceability, Entering A Global Acquisition Window.
- Thrivestate Launches“Fly Before You Buy” Program, Enabling International Buyers To Explore Dubai Before Committing
Comments
No comment